Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-18

Clinical Trial Update: Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Xiaflex for Dupuytren's Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: McMaster University | Conditions: Dupuytren's Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-07-18